Skip to main content

Table 4 The association between unconjugated bilirubin (UCB) concentrations and colorectal cancer risk by anatomical sub-sites in the EPIC study

From: Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses

Colorectal cancer

 

Men

Women

n cases/controls

Odds ratio (95% CI)

P

n cases/controls

Odds ratio (95% CI)

P

Adjusted model

658/658

1.19 (1.04–1.36)

0.01

728/728

0.86 (0.76–0.97)

0.02

Anatomical site

658/658

 

> 0.9

728/728

 

0.2

Colon

381/381

1.18 (0.99–1.42)

0.07

485/485

0.81 (0.70–0.95)

0.008

Rectum

277/277

1.19 (0.99–1.43)

0.06

243/243

0.95 (0.62–0.79)

0.79

Colon sub-site

339/339

 

0.1

447/447

 

0.9

Proximal

156/156

1.10 (0.83–1.47)

0.5

218/218

0.77 (0.62–0.95)

0.017

Distal

183/183

1.55 (1.15–2.11)

0.01

229/229

0.79 (0.62–1.00)

0.06

  1. EPIC (European Prospective Investigation into Cancer and Nutrition): Conditional logistic regression models were used to estimate odds ratios (OR) and 95% confidence intervals (CI) for associations between log-transformed UCB levels (log-UCB), standardized per one standard deviation (1-SD) increments, and CRC risk. The crude model was conditioned on the matching factors including study center, age at blood collection (1 year), fasting status and time (3 h intervals) at blood collection, among women, additionally by menopausal status (pre-, peri-, and post-menopausal or surgically menopausal), and hormone therapy (HT) (yes, no). The multivariable model was adjusted for level of education (none/primary school, technical/professional, secondary school, and university degree), BMI, height, smoking status (never, former, current smoker), physical activity (inactive, moderately inactive, moderately active, and active), alcohol consumption (g/day), dietary intakes of fiber (g/day), red meat (g/day), processed meats (g/day), dairy products (g/d), and total energy intake (kcal/day)
  2. Abbreviations: n number, P P value, CI confidence interval
  3. Cases matched 1:1 to control subjects
  4. Pheterogeneity